WALTHAM, Mass.--(BUSINESS WIRE)--
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving
science, has completed its previously announced acquisition of Alfa
Aesar, a leading global manufacturer of research chemicals, from Johnson
Matthey Plc, for £256 million (or approximately $400 million) in cash.
“With the close of the transaction, we now have the opportunity to fully
leverage our combined capabilities in laboratory chemicals to drive
growth,” said Marc N. Casper, president and chief executive officer of
Thermo Fisher Scientific. “The addition of Alfa Aesar products to our
existing chemicals portfolio offers customers greater access to a broad
offering that serves virtually every laboratory application – from
research to production.”
Alfa Aesar has approximately 480 employees at key locations in the
United Kingdom, United States, Germany, China, South Korea and India.
The business generated sales of approximately £78 million in 2014 and
will be integrated into Thermo Fisher’s Laboratory Products and Services
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving
science, with revenues of $17 billion and approximately 50,000 employees
in 50 countries. Our mission is to enable our customers to make the
world healthier, cleaner and safer. We help our customers accelerate
life sciences research, solve complex analytical challenges, improve
patient diagnostics and increase laboratory productivity. Through our
premier brands – Thermo Scientific, Applied Biosystems, Invitrogen,
Fisher Scientific and Unity Lab Services – we offer an unmatched
combination of innovative technologies, purchasing convenience and
comprehensive support. For more information, please visit www.thermofisher.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150930006722/en/
Source: Thermo Fisher Scientific Inc.